The Personalised Medicine Consortium (PMC) is keen to build new collaborations between clinicians and researchers from Luxembourg and to foster new synergies. To aid in this process, the five PMC-related institutions – the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Sciences Research Unit (LSRU) of the University of Luxembourg, Luxembourg Institute of Health (LIH), IBBL (Integrated Biobank of Luxembourg), and Laboratoire National de Santé (LNS) – have developed a fund to ‘pump prime’ new initiatives. This programme was first launched in 2014 and has been running successfully ever since. We are now pleased to announce a new call for 2020, to be launched on July 1, 2019.
This funding should be used to initiate new collaborative research projects on biomedical research between clinicians and researchers who are based in different research institutions. Priority will be given to projects that are innovative, are establishing new collaborations within Luxembourg and where preliminary data is needed prior to submitting an application to an external funding agency.
The main expected return on investment of such funding relies on:
– Solving unmet clinical needs with an innovative approach
– Fostering research interactions between the five biomedical research institutions
– Enabling researchers/clinicians to develop their project into an externally funded project, if successful
To know more about eligibility and restrictions, download the call overview and the application form.
Application forms should be completed and submitted to pmc@ibbl.lu by October 15, 2019.
Any questions should be directed to Clair MEEK +352 269 70 549.